Pulse Biosciences, Inc. (PLSE) Stock Grade

About Pulse Biosciences, Inc.'s fundamentals

Pulse Biosciences is a healthcare company with a market capitalization of $3.6 billion that reported flat year-over-year revenue growth with no increase in sales. The company posted a significant net loss in its latest annual statement, resulting in a net margin of -20,794.6%, indicating it is currently unprofitable. The company does not pay a dividend to shareholders. Given the absence of positive earnings, traditional valuation metrics like P/E ratio and return on equity are not meaningful for this company.